Shehzad S. Basaria MD

Endocrinology•Boston, MA

Diabetes, Gonad Disorders & Reproductive, Lipid Metabolism

Associate Professor of Medicine, Brigham and Women’s Hospital, Harvard Medical School

Join to View Full Profile

221 Longwood AveBLI-541Boston, MA 02115
Phone+1 617-525-9144
Fax+1 617-525-9148

Education & Training

Johns Hopkins UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2001
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1995 - 1998
Aga Khan Medical CollegeClass of 1993

Certifications & Licensure

MA State Medical License 2008 - 2025
MD State Medical License 2001 - 2010
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

TOM: Testosterone in Older Men With Sarcopenia Start of enrollment: 2005 Jan 01
Terminated
Phase 4
Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression Therapy Start of enrollment: 2005 Jun 01
Completed
Phase 4
Effects of Testosterone Replacement on Pain Sensitivity and Pain Perception Start of enrollment: 2006 Apr 01
Completed
Phase 2
TDSM- Testosterone Dose Response in Surgically Menopausal Women Start of enrollment: 2009 Jan 01
Completed
Not Applicable
Effect of Testosterone in Men With Erectile Dysfunction Start of enrollment: 2006 Nov 01
Completed
Phase 4
Optimizing Protein Intake in Older Americans With Mobility Limitations Start of enrollment: 2011 May 01
Completed
Phase 3
Testosterone Replacement in Male Cancer Survivors with Fatigue and Low Testosterone Start of enrollment: 2021 Mar 22
RECRUITING
PHASE2
Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency Start of enrollment: 2021 Jan 12
RECRUITING
PHASE2
RESIST-ADT (Androgen Deprivation Therapy) Start of enrollment: 2020 Dec 01
COMPLETED
NA
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism Start of enrollment: 2022 Jan 10
RECRUITING
PHASE2
Join now to see all

Publications & Presentations

PubMed

Opioid-induced androgen deficiency in men: Prevalence, pathophysiology, and efficacy of testosterone therapy.
Hussein Kafel, Milena Braga-Basaria, Shehzad Basaria
Andrology. 2025-02-21
2 citations
Insulin resistance during androgen deprivation therapy in men with prostate cancer.
Shehzad Basaria, Mary-Ellen Taplin, Marie McDonnell, Donald C Simonson, Alexander P Lin
Cancer. 2024-11-01
2 citations
Selective Androgen Receptor Modulators-Transformative Drugs or Heralds of the Next Drug Epidemic?
Henrik A Hahamyan, Shehzad Basaria
JAMA. 2024-04-23

Journal Articles

Metabolic Changes in Androgen Deprived Non-Diabetic Men with Prostate Cancer Are Not Mediated by Cytokines or aP2
Shehzad Basaria, MD, The Journal of Clinical Endocrinology and Metabolism
Long-Term Testosterone Supplementation in Older Men Attenuates Age-Related Decline in Aerobic Capacity
Shehzad Basaria, Shalender Bhasin, The Journal of Clinical Endocrinology and Metabolism

Lectures

Contributors to the Substantial Variation in on‐Treatment Testosterone Levels in Men Receiving Transdermal Testosterone Gels in Randomized Trials
ENDO 2019 - New Orleans, LA - 3/23/2019

Press Mentions

The Facts About Testosterone and SexMay 19th, 2020
Adult-Onset HypogonadismJune 21st, 2016
Testosterone Therapy Failed to Improve Ejaculatory DysfunctionJuly 9th, 2015
Join now to see all

Grant Support

Isoflavones In Prostate Cancer Undergoing Androgen Deprivation TherapyNational Center For Research Resources2006–2007

Professional Memberships

Endocrine Society - ENDO
Member